News Image

Top movers in Tuesday's after hours session

By Mill Chart

Last update: Apr 9, 2024

Get insights into the top gainers and losers of Tuesday's after-hours session.

Today's after hours gainers

TickerChangeComment
MRIN68.97%Impressive after-hours gains for MARIN SOFTWARE INC (NASDAQ:MRIN) as its stock price advanced 68.97% to $0.49 during Tuesday's after-hours session. Earlier today the company had a press release: Marin Software Enhances Its Microsoft Advertising Integration.
INAB31.19%Positive after-hours movement for IN8BIO INC (NASDAQ:INAB) as its shares recorded a 31.19% increase, reaching $1.43 during Tuesday's after-hours session. Earlier today the company had a press release: IN8bio Announces New Preclinical Data for Gamma-Delta nsCAR-T Cell Therapy Platform at AACR 2024.
LIFE9.83%After the regular session, ATYR PHARMA INC (NASDAQ:LIFE) continues to impress in the after-hours session, with a 9.83% increase to $1.89. In the last 6 months the stock gained 23.74%.
PFMT8.96%PERFORMANT FINANCIAL CORP (NASDAQ:PFMT) rose 8.96% to $2.92 during Tuesday's after hours session. Earlier today the company had a press release: Performant Financial Corporation Acquires Artificial Intelligence Technology in Support of Its Scale Initatives.
RVMD8.46%REVOLUTION MEDICINES INC's (NASDAQ:RVMD) shares rose 8.46% to $35.78. In the last year the stock gained 49.01%.
FTEL8.26%Positive market activity for FITELL CORP (NASDAQ:FTEL) after regular trading hours, with a 8.26% increase to $7.6 in the after-hours session on Tuesday. After today's -10.46% drop, there is a noticeable rebound in NASDAQ:FTEL during today's after-hours session.
UCAR7.78%Promising after-hours performance observed for U POWER LTD (NASDAQ:UCAR) as its shares surged 7.78% to $5.68 during Tuesday's after-hours trading. The stock is trading 59.21% lower than 3 months ago.
BCLI7.3%BRAINSTORM CELL THERAPEUTICS (NASDAQ:BCLI) showcases remarkable after-hours performance, with a 7.3% rise to $0.63 during Tuesday's after-hours trading. After experiencing a -20.21% decline earlier today, NASDAQ:BCLI shows signs of a rebound in today's after-hours session.
JAGX6.67%Positive market activity for JAGUAR HEALTH INC (NASDAQ:JAGX) after regular trading hours, with a 6.67% increase to $0.1 in the after-hours session on Tuesday. Shareholders saw the stock price going 26.05% higher in the past month.
ATXI6.47%AVENUE THERAPEUTICS INC's (NASDAQ:ATXI) shares rose 6.47% to $0.16. Shareholders saw the stock price going 75.51% lower is the past 6 months.

For the full after hours gainers list go to our after hours gainers page.

Today's after hours losers

TickerChangeComment
PRFX-17.22%Following a -13.21% loss in the regular session, NASDAQ:PRFX exhibits further decline during today's after-hours session. The regular session ended on a negative note with NASDAQ:PRFX closing -13.21% lower, and the after-hours session reflects a continuation of the bearish sentiment.
SGH-11.5%SMART GLOBAL HOLDINGS INC's (NASDAQ:SGH) stock price decreased by 11.5% to $22.94. The company's earnings where released Yesterday. A press release (SGH Reports Second Quarter Fiscal 2024 Financial Results) was released earlier today.
CLDI-11.29%After today's 63.16% drop, NYSEARCA:CLDI shows further decline during today's after-hours session with a 11.29% decrease. Despite a strong 63.16% gain earlier today, NYSEARCA:CLDI is experiencing a reversal in after-hours trading, with prices declining by 11.29%. A press release (Calidi Biotherapeutics Presents New Data on the Mechanisms of Action for Virotherapy-Loaded Stem Cells Used in the Company’s Novel Immunotherapies at the AACR Annual Meeting 2024) was released yesterday.
SLNA-11.08%Price volatility persists as NASDAQ:SLNA closed the regular session with a 96.25% loss, and the downward trend continues in the after-hours session. Price movements remain volatile as NASDAQ:SLNA gives back 96.25% of its earlier gains in the after-hours session.
SMFL-8.96%SMART FOR LIFE INC's (NASDAQ:SMFL) stock price is declining with 8.96% to a price of $0.61. The stock is trading 20.11% lower than a month ago.
WTO-8.37%UTIME LTD's (NASDAQ:WTO) shares fell 8.37% to $0.27. The stock is trading 22.79% higher than a month ago.
ALBT-8.11%AVALON GLOBOCARE CORP's (NASDAQ:ALBT) stock price decreased by 8.11% to $0.34. The positive momentum earlier in the day is waning as NASDAQ:ALBT retraces 14.2% during the after-hours session.
BENF-7.5%Following a %ABSPERF% loss in the regular session, NASDAQ:BENF exhibits further decline during today's after-hours session. In the last 3 months the share price dropped with 78.54%.
HEAR-7.07%TURTLE BEACH CORP's (NASDAQ:HEAR) stock price saw a decrease of 7.07% to $15.5 during Tuesday's after-hours session. Earlier today the company had a press release: Turtle Beach Announces Update on Its Return of Capital Strategy to Shareholders.
AUUD-6.76%AUDDIA INC's (NASDAQ:AUUD) shares fell 6.76% to $2.62. NASDAQ:AUUD already had a hard day: closing -20.62% lower during the regular session. A press release (Auddia Announces Issuance of Core AI Patent) was released two days ago.

For the full after hours loser list go to our after hours losers page.

Back

REVOLUTION MEDICINES INC

NASDAQ:RVMD (5/8/2024, 3:01:50 PM)

After market: 38.31 0 (0%)

38.31

-0.57 (-1.47%)

RVMD News

News Image41 minutes ago - Revolution Medicines, Inc.Revolution Medicines Reports First Quarter 2024 Financial Results and Update on Corporate Progress

Revolution Medicines to hold webcast today at 4:30 p.m. Eastern Time...

News Image7 days ago - Market News VideoRevolution Medicines Larger Than S&P 500 Component Bio-Rad Laboratories
News Image7 days ago - Revolution Medicines, Inc.Revolution Medicines to Report Financial Results for First Quarter 2024 After Market Close on May 8, 2024

REDWOOD CITY, Calif., May 01, 2024 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted...

News Imagea month ago - Revolution Medicines, Inc.Revolution Medicines Announces Publication on the Discovery of and Translational Research for RMC-6236, an Investigational RAS(ON) Multi-Selective Tri-Complex Inhibitor Designed to Block Full Spectrum of Oncogenic RAS(ON) Proteins

Simultaneous publication and presentation of RMC-6236 chemical structure, preclinical data and case studies during the “KRAS: Broadening the Attack Beyond...

News Imagea month ago - Revolution Medicines, Inc.Revolution Medicines Announces Publications on the Discovery and Preclinical Profile of Representative of a New Class of RAS(ON) Multi-Selective Inhibitors Designed to Block Full Spectrum of Oncogenic RAS(ON) Proteins

Two original papers in Nature highlight the discovery and translational implications of RMC-7977, a RAS(ON) multi-selective tri-complex inhibitor that...

News Imagea month ago - Revolution Medicines, Inc.Revolution Medicines to Participate in Upcoming Investor Conferences

REDWOOD CITY, Calif., April 04, 2024 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted...

News Imagea month ago - Revolution Medicines, Inc.Revolution Medicines to Deliver Multiple Presentations at the Upcoming American Association for Cancer Research Annual Meeting 2024

REDWOOD CITY, Calif., March 28, 2024 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted...

News Image2 months ago - Revolution Medicines, Inc.Revolution Medicines Reports Fourth Quarter and Full Year 2023 Financial Results and Update on Corporate Progress

Revolution Medicines to hold webcast today at 4:30 p.m. Eastern Time...

News Image3 months ago - Market News VideoFirst Week of September 20th Options Trading For Revolution Medicines (RVMD)
News Image3 months ago - Revolution Medicines, Inc.Revolution Medicines to Report Financial Results for Fourth Quarter and Full Year 2023 After Market Close on February 26, 2024

REDWOOD CITY, Calif., Feb. 20, 2024 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing novel...

News Image3 months ago - Market News VideoCommit To Buy Revolution Medicines At $24, Earn 14.1% Annualized Using Options
News Image3 months ago - Revolution Medicines, Inc.Revolution Medicines to Participate in Upcoming Investor Conferences

REDWOOD CITY, Calif., Feb. 01, 2024 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted...

RVMD Links
Follow us for more